Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peanut OIT IMPACT Follow-up
NCT03345160Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2018
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in peanut allergy, sponsored by Johns Hopkins University. Primary endpoint: Number of Participants With Treatment-related Adverse Events up to 52 weeks. Started Apr 2018; status: completed.
02
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT03345160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345160.